Aprea Therapeutics (APRE) Exchange Rate Effect (2018 - 2026)
Aprea Therapeutics (APRE) posted quarterly Exchange Rate Effect of -$348.0 for Q1 2026, down 124.89% year-over-year from $1398.0 in Q1 2025, and down 127.34% quarter-over-quarter from $1273.0 in Q4 2025.
Aprea Therapeutics (APRE) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Aprea Therapeutics (APRE) has reported Exchange Rate Effect for 9 consecutive years, with -$348.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 124.89% year-over-year to -$348.0; the TTM figure through Mar 2026 stood at $2933.0 (up 187.06% YoY), while the FY2025 annual figure was $4679.0, up 165.16% from the prior year.
- Exchange Rate Effect eased to -$348.0 in Q1 2026 per APRE's latest filing, from $1273.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $313254.0 in Q2 2022 and bottomed at -$403968.0 in Q4 2022.
- Historically, Exchange Rate Effect has averaged $1618.2 across 5 years, with a median of $383.0 in 2023.
- On a YoY basis, Exchange Rate Effect climbed as much as 816.8% in 2024 and fell as far as 6525.07% in 2024.
- Aprea Therapeutics' Exchange Rate Effect stood at -$403968.0 in 2022, then soared by 100.09% to $383.0 in 2023, then sank by 6525.07% to -$24608.0 in 2024, then surged by 105.17% to $1273.0 in 2025, then sank by 127.34% to -$348.0 in 2026.
- Business Quant data shows APRE's Exchange Rate Effect at -$348.0 in Q1 2026, $1273.0 in Q4 2025, and -$600.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Aprea Therapeutics | 35.09 Mn | 35.09 Mn | - | -695.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -695.00 |
| Jun 30, 2026 | -695.00 |
| Mar 31, 2026 | -348.00 |
| Mar 31, 2026 | -348.00 |
| Dec 31, 2025 | 1,273.00 |
| Dec 31, 2025 | 1,273.00 |
| Sep 30, 2025 | -600.00 |
| Sep 30, 2025 | -600.00 |
| Jun 30, 2025 | 2,608.00 |
| Jun 30, 2025 | 2,608.00 |
| Mar 31, 2025 | 1,398.00 |
| Mar 31, 2025 | 1,398.00 |
| Dec 31, 2024 | -24,608.00 |
| Dec 31, 2024 | -24,608.00 |
| Sep 30, 2024 | 24,665.00 |
| Sep 30, 2024 | 24,665.00 |
| Jun 30, 2024 | -4,824.00 |
| Jun 30, 2024 | -4,824.00 |
| Mar 31, 2024 | -2,414.00 |
| Mar 31, 2024 | -2,414.00 |